Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244
Published February 5, 2014 · Recall initiated: April 15, 2013
Summary
FDA records drug Class I recall D-1052-2014, published February 5, 2014 and initiated April 15, 2013. Recalling firm: NuVision Pharmacy, Inc.; Status: Terminated; Reported quantity: 122 vials; Lot: Lot #:N10172012@11, Exp 10/17/2013. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- NuVision Pharmacy, Inc.
- Distributor
- Nationwide
- Lot
- Lot #:N10172012@11, Exp 10/17/2013
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHCG (Lyophilized) Stock # 21714, 5000 IUnits-5 mL vial, Compounded by NuVision Pharmacy Dallas, TX 75244February 5, 2014
- FDAHydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only.February 5, 2014
- FDAHydravax High Potency Diuretic Weight Loss Solution, Pharmaceutical Grade, 45 capsules per bottle, DietaryFebruary 5, 2014
- FDAShortbread Almond Crescent cookies sold under the Lambs Farm brand and packaged in a plastic bag with a netFebruary 5, 2014
- FDASoliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mLFebruary 5, 2014
- FDAMethylcobalamin (Buffered) Injection,1 mg/mL, 30 mL vial, Stock# 11126, Preservative Free, Compounded byMay 22, 2013
Questions about this recall
Was Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244 recalled?
Yes. FDA published recall D-1052-2014 on February 5, 2014. Reported hazard: Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release